hepatitis
Precision BioSciences Launches First Hepatitis B Gene-Editing Trial
PBGENE-HBV is designed to eliminate covalently closed circular DNA and stop the hepatitis B virus from replicating, using the company's Arcus gene-editing platform.
Precision BioSciences Putting Together IND Data Package for Hepatitis B Gene-Editing Therapy
The firm said it plans to submit an investigational new drug application or a clinical trial application for the gene-editing therapy in 2024.
Lion TCR to Begin Phase Ib/II Trial of Autologous Liver Cancer T-Cell Receptor Therapy
The FDA has cleared an investigational new drug application for Lion's LioCyx-M004 for advanced hepatitis B virus-related hepatocellular carcinoma patients.